Randomized Phase-III Study of Low-Dose Cytarabine and Etoposide + /− All-Trans Retinoic Acid in Older Unfit Patients with NPM1-Mutated Acute Myeloid Leukemia

Investigators evaluated the impact of all-trans retinoic acid in combination with non-intensive chemotherapy in older unfit patients (> 60 years) with newly diagnosed NPM1-mutated acute myeloid leukemia.
[Scientific Reports]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News